D81.6 Major histocompatibility complex class I deficiency

Name of the Condition

• Major histocompatibility complex class I deficiency

Summary

Major histocompatibility complex class I deficiency is a rare inherited immunodeficiency disorder characterized by impaired cellular immune responses due to defects in the major histocompatibility complex (MHC) class I molecules. These molecules are critical for presenting antigens to CD8+ T cells, and their deficiency leads to increased susceptibility to viral infections and other pathogens. The condition disrupts the body's ability to recognize and eliminate infected cells, resulting in recurrent or severe infections.

Causes

Major histocompatibility complex class I deficiency is caused by genetic mutations affecting genes involved in the production or function of MHC class I molecules. These mutations disrupt the assembly, transport, or surface expression of MHC class I proteins, impairing antigen presentation. Inheritance is typically autosomal recessive, with mutations in genes such as TAP1, TAP2, or tapasin leading to the disorder.

Risk Factors

• Genetic predisposition, often with a family history of immunodeficiency disorders.
• Consanguinity (parents who are closely related) increasing the risk of autosomal recessive forms.
• Certain ethnic backgrounds with higher prevalence of specific genetic mutations.

Symptoms

• Recurrent or severe viral infections (e.g., herpes simplex, cytomegalovirus).
• Chronic respiratory infections.
• Skin lesions or rashes.
• Failure to thrive in infants.
• Hepatosplenomegaly (enlarged liver and spleen) in some cases.

Diagnosis

Diagnosis involves clinical evaluation of recurrent infections, laboratory testing to assess immune function, and genetic testing to identify mutations in MHC class I-related genes. Flow cytometry may show reduced or absent MHC class I expression on cell surfaces. Additional tests, such as viral load measurements or imaging, may be used to assess organ involvement.

Treatment Options

Treatment focuses on managing infections with antiviral or antimicrobial therapies and supporting immune function. Hematopoietic stem cell transplantation (HSCT) may be considered for severe cases to restore immune competence. Regular monitoring and prophylactic treatments are often necessary to prevent complications.

Prognosis and Follow-Up

Prognosis varies depending on the severity of infections and response to treatment. Early diagnosis and intervention improve outcomes, but recurrent infections may persist. Long-term follow-up with immunologists is essential to monitor immune function, manage complications, and adjust therapies as needed.

Complications

• Chronic or persistent viral infections.
• Organ damage from recurrent infections.
• Increased risk of malignancies due to impaired immune surveillance.
• Growth delays or developmental issues in children.

Lifestyle & Prevention

• Practice good hygiene to reduce infection risk.
• Avoid exposure to known pathogens (e.g., sick contacts).
• Ensure up-to-date vaccinations (as recommended by a healthcare provider).
• Promptly treat any signs of infection to prevent progression.

When to Seek Professional Help

Seek medical attention if experiencing recurrent or severe infections, unexplained rashes, or persistent fever. Early evaluation is critical for timely diagnosis and management to prevent complications.

Tips for Medical Coders

When coding for Major histocompatibility complex class I deficiency (ICD10CM code D81.6), ensure documentation supports the diagnosis, including clinical findings, laboratory results, and genetic testing if performed. Verify that the code aligns with the specific immunodeficiency subtype and any associated complications. Accurate coding requires clear documentation of the condition's impact on immune function and any treatments administered.